ÖZKAN, E. Et Al. 2016. Impact of 18F-FDG PET/CT for Detecting Primary Tumor Focus in Patients with Histopathologically Proven Metastasis. International Journal of Nuclear Medicine Research , vol.3 .

ÖZKAN, E., SOYDAL, Ç., ARAZ, M., & KÜÇÜK, N. Ö., (2016). Impact of 18F-FDG PET/CT for Detecting Primary Tumor Focus in Patients with Histopathologically Proven Metastasis. International Journal of Nuclear Medicine Research , vol.3.

ÖZKAN, ELGİN Et Al. "Impact of 18F-FDG PET/CT for Detecting Primary Tumor Focus in Patients with Histopathologically Proven Metastasis," International Journal of Nuclear Medicine Research , vol.3, 2016

ÖZKAN, ELGİN Et Al. "Impact of 18F-FDG PET/CT for Detecting Primary Tumor Focus in Patients with Histopathologically Proven Metastasis." International Journal of Nuclear Medicine Research , vol.3, 2016

ÖZKAN, E. Et Al. (2016) . "Impact of 18F-FDG PET/CT for Detecting Primary Tumor Focus in Patients with Histopathologically Proven Metastasis." International Journal of Nuclear Medicine Research , vol.3.

@article{article, author={ELGİN ÖZKAN Et Al. }, title={Impact of 18F-FDG PET/CT for Detecting Primary Tumor Focus in Patients with Histopathologically Proven Metastasis}, journal={International Journal of Nuclear Medicine Research}, year=2016}